Skip to content
methysergide

Structure via PubChem · Public domain (PubChem)

EntityQ424442· pop 15· linked from 1,709 articles

methysergide

Sign in to save

Also known as 1-methylmethylergonovine, Deseril®, Sansert®, UML-491

Methysergide, sold under the brand names Deseril and Sansert, is a monoaminergic medication which is used in the prevention and treatment of migraine and cluster headaches. It has been withdrawn from the market in the United States and Canada due to safety concerns. The drug has also been found to produce psychedelic effects at high doses. It is taken orally.

Chemical data

Formula
C21H27N3O2
Molecular weight
353.5 g/mol
IUPAC name
(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
SMILES
CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C
InChIKey
KPJZHOPZRAFDTN-ZRGWGRIASA-N
XLogP
2.3
Polar surface area
57.5 Ų
H-bond donors
2
H-bond acceptors
3
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
1962
Admin. routes
oral
Indications
migraine disorder

via ChEMBL · EBI

Research

4,681 papers

via PubMed

Wikidata facts

Mass
353.21
Has use
medication
Show 6 more facts
defined daily dose
4
chemical formula
C₂₁H₂₇N₃O₂
subject has role
serotonin antagonist
isomeric SMILES
CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C
canonical SMILES
CCC(CO)NC(=O)C1CN(C2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C
Commons category
Methysergide
Sources (4)

via Wikidata · CC0

~13 min read

Encyclopedic overview

21 sections
Contents
  • Medical uses
  • Migraine and cluster headaches
  • Other uses
  • Side effects
  • Interactions
  • Pharmacology
  • Pharmacodynamics
  • Pharmacokinetics
  • Chemistry
  • Analogues
  • Natural occurrence
  • History
  • Society and culture
  • Recreational use
  • Controversy
  • Legal status
  • Canada
  • United States
  • See also
  • References
  • External links

Methysergide, sold under the brand names Deseril and Sansert, is a monoaminergic medication which is used in the prevention and treatment of migraine and cluster headaches. It has been withdrawn from the market in the United States and Canada due to safety concerns. The drug has also been found to produce psychedelic effects at high doses. It is taken orally.

The drug is a prodrug of methylergometrine (methylergonovine), which circulates at levels about 10times higher than those of methysergide. Whereas methysergide is a mixed agonist of some serotonin receptors (e.g., the serotonin 5-HT1 receptors) and antagonist of other serotonin receptors (e.g., the serotonin 5-HT2 receptors), methylergonovine is a non-selective agonist of most of the serotonin receptors, including of both the serotonin 5-HT1 and 5-HT2 receptor subgroups. Methysergide and methylergometrine are ergolines and lysergamides and are related to the ergot alkaloids.

Excerpted from Wikipedia’s “methysergide” article, available under the CC BY-SA 4.0 licence.

Gallery (2)